Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$17995
Buy Report Download FREE Resources

Published: May 31, 2026 Report Code: GDHCHT739-ST

Select Item

Explore the 7MM male infertility therapeutics market with forecasts to 2035. Analyze epidemiology, market size, treatment trends, pipeline therapies, clinical trials, unmet needs, and competitive dynamics across the US, Europe, and Japan.

Report Value Proposition – Why Does the Male Infertility Therapeutics Market Matter?

Male infertility remains an important yet underserved therapeutic area, with growing attention on improving diagnosis, understanding disease mechanisms, and developing targeted treatment options. Although diagnosed prevalence is expected to remain relatively stable across the seven major pharmaceutical markets (7MM), significant unmet clinical needs and limited approved therapies continue to create opportunities for innovation and investment.

GlobalData’s Male Infertility Therapeutics Market Analysis provides a comprehensive assessment of the market across the US, France, Germany, Italy, Spain, the UK, and Japan. Combining epidemiology, treatment patterns, market forecasts, pipeline analysis, competitive intelligence, and clinical trial insights, the report supports strategic decision-making for pharmaceutical companies, investors, and healthcare stakeholders through 2035.

You can use this report to:

  • Understand the current and future male infertility therapeutics market
  • Analyze epidemiology and diagnosed patient populations across the 7MM
  • Evaluate treatment usage patterns and market forecasts
  • Benchmark pipeline therapies and competitive developments
  • Identify unmet clinical needs and commercial opportunities
  • Support licensing, investment, and portfolio planning decisions

Key Insights in the Male Infertility Therapeutics Market

The report explores the major clinical and commercial factors shaping the future of male infertility treatment.

Key themes include:

  • Diagnosed prevalence forecasts across the seven major pharmaceutical markets
  • Market outlook for male infertility therapeutics through 2035
  • Treatment usage patterns and annual therapy costs
  • Emerging pipeline therapies and novel mechanisms of action
  • Clinical trial activity and late-stage development programs
  • Unmet medical needs driving future innovation
  • Competitive landscape and market dynamics
  • Clinical, environmental, and commercial factors influencing market growth

Scope

What Will You Learn from This Male Infertility Market Report?

This report provides insight into:

  • Male infertility epidemiology

  • Disease symptoms, diagnosis, and management

  • Diagnosed patient population forecasts

  • Therapeutics market size and revenue forecasts

  • Treatment utilization trends

  • Cost of therapy analysis

  • Pipeline drugs and mechanisms of action

  • Clinical trial mapping

  • Competitive landscape assessment

  • Market drivers, restraints, and future opportunities

Who Should Buy This Report?

This report is valuable for:

  • Pharmaceutical companies

  • Biotechnology companies

  • Reproductive health specialists

  • Women’s and men’s health therapy developers

  • Business development and licensing teams

  • Strategy and market intelligence professionals

  • Healthcare investors

  • Clinical development teams

  • Consultants and industry advisors

  • Commercial and product management teams

How Companies Use This Male Infertility Market Analysis

Pharmaceutical companies use this report to evaluate market opportunities, prioritize pipeline investments, and identify emerging therapies addressing unmet needs in male infertility.

Business development and licensing teams leverage the competitive analysis to assess partnership opportunities, benchmark pipeline assets, and support in-licensing or acquisition decisions.

Commercial, strategy, and investment teams use the report to understand market dynamics, forecast future demand, and develop evidence-based commercialization strategies across the seven major pharmaceutical markets.

Reasons to Buy

Benchmark Your Strategy Against the Future Male Infertility Treatment Landscape

This report helps organizations benchmark their strategies against evolving market and clinical trends.

It provides comparative insight into:

  • Epidemiology trends

  • Market forecasts

  • Treatment utilization

  • Pipeline innovation

  • Clinical trial activity

  • Competitive positioning

  • Market opportunities

  • Unmet clinical needs

Built on Trusted GlobalData Pharmaceutical Intelligence

GlobalData’s Male Infertility Therapeutics Market Analysis is built on proprietary pharmaceutical databases, epidemiology models, pipeline intelligence, clinical trial analysis, and expert market forecasting.

Trusted by global pharmaceutical companies, biotechnology firms, investors, and healthcare organizations, GlobalData delivers actionable intelligence that supports portfolio strategy, market forecasting, and competitive decision-making.

GlobalData’s analysts provide deep expertise across reproductive health, specialty pharmaceuticals, epidemiology, clinical development, and global therapeutic markets.

Position Your Business for Opportunities in the Male Infertility Therapeutics Market

As research advances and interest in male reproductive health continues to grow, organizations that understand the evolving treatment landscape, competitive environment, and emerging pipeline will be better positioned to capitalize on new commercial opportunities and support innovation across the global male infertility therapeutics market through 2035.

Theravia SAS
ReproNovo SA
CDT Equity Inc
Igyxos SA

Table of Contents

Table of Contents

1. Preface

1.1. Contents

1.2. Abbreviations

1.3. Related Reports

2. Executive Summary

3. Disease Overview

3.1. Overview of Male Infertility

3.2. Male Infertility Strengths, Weaknesses, Opportunities, and Threats Analysis

3.3. Classification of Male Infertility

3.4. Diagnosis of Male Infertility

4. Epidemiology

4.1. Diagnosed Prevalent Cases of Male Infertility, Men, N, Ages 15-49 Years, 2025–35

4.2. Age-Specific Diagnosed Prevalent Cases of Male Infertility, N, Men, Ages 15-49 Years, 2025

4.3. Diagnosed Prevalent Cases of Oligozoospermia, N, Men, Ages 15–49 Years, 2025

5. Current Treatment Options

5.1. Treatment Paradigm

5.2. Current Treatment Options

5.3. Product Profile: Menotropin

5.4. Product Profile: Chorionic Gonadotropin

5.5. Product Profile: Mesterolone

5.6. Product Profile: Urofollitropin

5.7. Product Profile: Clomiphene citrate

5.8. Current Treatment Options: KOL Perspectives

6. Unmet Needs and Opportunities

6.1. Unmet Needs in Male Infertility

6.2. Overall Lack of Pharmacological Therapies in Male Infertility

6.3. Knowledge Gaps in Causes of Male Infertility

6.4. Prioritization of Female Treatments for Infertility

6.5. Difficulty in Recruitment for Clinical Trials

7. R&D Strategies

7.1. Trends in Deal-Making in Male Infertility

7.2. Trends in Clinical Trial Design in Male Infertility

8. Pipeline Assessment

8.1. Male Infertility Pipeline Overview

8.2. Late Stage Pipeline Agents for Male Infertility

8.3. Product Profile: Prokrea’s Pentoxifylline

8.4. Male Infertility Late-Stage Clinical Trials by Phase

9. Market Outlook

9.1. Male Infertility Market Forecast

9.2. Male Infertility by Drug and Classes, 2025 and 2035

9.3. Market Drivers and Barriers

10. Appendix

10.1. Bibliography

10.2. About the Authors

11. Contact Us

Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035 standard reports
Currency USD
$17,995

Can be used by individual purchaser only

Most Popular
$35,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$53,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Oligozoospermia reports
Pharmaceuticals
New
Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence
$495 | July 2026
Pharmaceuticals
New
Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment,…
$17,995 | July 2026
Pharmaceuticals
New
Melanoma: Epidemiology Forecast to 2035
$9,995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035 in real time.

  • Access a live Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more